Potential biochemical pathways for the relationship between sleep duration and mortality

Sleep Medicine

Volumn 14, Issue 1, 2013, Pages 98-104

  Li, Ying ^a   Sato, Yasuto ^b   Yamaguchi, Naohito ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Biochemical; Cohort studies; Epidemiology; In blood; Mortality; Sleep

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLINESTERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYSIS OF COVARIANCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; JAPAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEX DIFFERENCE; SLEEP TIME; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; SLEEP; TIME FACTORS; YOUNG ADULT;

EID: 84872314283     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.08.020     Document Type: Article

References (39)

1. Nagai M., Hoshide S., Kario K. Sleep duration as a risk factor for cardiovascular disease - a review of the recent literature. Curr Cardiol Rev 2010, 6(1):54-61.
2. Kronholm E., Laatikainen T., Peltonen M., Sippola R., Partonen T. Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med 2011, 12(3):215-221.
3. Chaput J.P., Després J.P., Bouchard C., Tremblay A. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 2007, 50(11):2298-2304.
4. Heslop P., Smith G.D., Metcalfe C., Macleod J., Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 2002, 3:305-314.
5. Tamakoshi A., Ohno Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 2004, 27:51-54.
6. Patel S.R., Ayas N.T., Malhotra M.R., White D.P., Schernhammer E.S., Speizer F.E., et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004, 27:440-444.
7. Knutson K.L., Turek F.W. The U-shaped association between sleep and health: the 2 peaks do not mean the same thing. Sleep 2006, 29:878-879.
8. Ayas N.T., White D.P., Manson J.E., Stampfer M.J., Speizer F.E., Malhotra A., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003, 163:205-209.
9. Patel S.R., Malhotra A., Gottlieb D.J., White D.P., Hu F.B. Correlates of long sleep duration. Sleep 2006, 29(7):881-889.
10. Kripke D.F., Simons R.N., Garfinkel L., Hammond E.C. Short and long sleep and sleeping pills. Arch Gen Psychaitry 1979, 36:103-116.
11. Qureshi A.I., Giles W.H., Croft J.B., Bliwise D.L. Habitual sleep patterns and risk for stroke and coronary artery disease: a 10-year follow-up from NHANES I. Neurology 1997, 48:904-911.
12. Wingard D.B., Berkman L.F. Mortality risk associated with sleeping patterns among adults. Sleep 1983, 6:102-107.
13. Aldabal L., Bahammam A.S. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J 2011, 5:31-43.
14. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
15. Spiegel K., Leproult R., L'Hermite-Baleriaux M., Copinschi G., Penev P.D., Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89:5762-5771.
16. Spiegel K., Sheridan J.F., Van Cauter E. Effect of sleep deprivation on response to immunization. JAMA 2002, 288(12):1471-1472.
17. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006, 166(16):1756-1762.
18. Irwin M.R., Wang M., Ribeiro D., Cho H.J., Olmstead R., Breen E.C., et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 2008, 64(6):538-540.
19. Kotronoulas G., Stamatakis A., Stylianopoulou F. Hormones, hormonal agents, and neuropeptides involved in the neuroendocrine regulation of sleep in humans. Hormones (Athens) 2009, 8(4):232-248.
20. van den Berg J.F., Miedema H.M., Tulen J.H., Neven A.K., Hofman A., Witteman J.C., et al. Long sleep duration is associated with serum cholesterol in the elderly: the Rotterdam Study. Psychosom Med. 2008, 70:1005-1011.
21. Hirotsu C., Tufik S., Bergamaschi C.T., Tenorio N.M., Araujo P., Andersen M.L. Sleep pattern in an experimental model of chronic kidney disease. Am J Physiol Renal Physiol 2010, 299:F1379-F1388.
22. Kar S., Routray A., Nayak B.P. Functional network changes associated with sleep deprivation and fatigue during simulated driving: validation using blood biomarkers. Clin Neurophysiol 2011, 122:966-974.
23. Krueger P.M., Friedman E.M. Sleep duration in the United States: a cross-sectional population-based study. Am J Epidemiol 2009, 169:1052-1063.
24. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1(3):e62.
25. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:498-504.
26. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E., Miller M.A., Kumari M., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30(12):1659-1666.
27. Amagai Y., Ishikawa S., Gotoh T., Doi Y., Kayaba K., Nakamura Y., et al. Sleep duration and mortality in Japan: the Jichi Medical School Cohort Study. J Epidemiol 2004, 14:124-128.
28. Akerstedt T., Nilsson P.M. Sleep as restitution: an introduction. J Intern Med 2003, 254:6-12.
29. Chaput J.P., Després J.P., Bouchard C., Astrup A., Tremblay A. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance. analyses of the Quebec Family Study. Sleep Med 2009, 10(8):919-924.
30. Knutson K.L., Van Cauter E., Zee P., Liu K., Lauderdale D.S. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the coronary artery risk development in young adults (CARDIA) sleep study. Diabetes Care 2011, 34(5):1171-1176.
31. Gangwisch J.E., Malaspina D., Babiss L.A., Opler M.G., Posner K., Shen S., et al. Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health. Sleep 2010, 33(7):956-961.
32. Grandner M.A., Drummond S.P. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007, 11:341-360.
33. Lan Tzuo-Yun, Lan Tsuo-Hung, Wen Chi-Pang, Lin Yu-Hsuan, Chuang Yi-Li Nighttime sleep, Chinese afternoon nap, and mortality in the elderly. Sleep 2007, 30:1105-1110.
34. Nieoullon A., Bentué-Ferrer D., Bordet R., Tsolaki M., Förstl H. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin 2008, 24(12):3357-3367.
35. Kalonia H., Bishnoi M., Kumar A. Possible mechanism involved in sleep deprivation-induced memory dysfunction. Methods Find Exp Clin Pharmacol 2008, 30(7):529-535.
36. Larsson A., Hassan M., Ridefelt P., Axelsson J. Circadian variability of bilirubin in healthy men during normal sleep and after an acute shift of sleep. Chronobiol Int 2009, 26(8):1613-1621.
37. Stavropoulos N., Young M.W. Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron 2011, 72:964-976.
38. Youngstedt S.D., Kline C.E., Zielinski M.R., Kripke D.F., Devlin T.M., Bogan R.K., et al. Tolerance of chronic 90-minute time-in-bed restriction in older long sleepers. Sleep 2009, 32:1467-1479.
39. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E., Miller M.A., Kumari M., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30(12):1659-1666.